Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merck Sharp & Dohme LLC
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient is at least 18 years old with refractory/relapsed AML
* If untreated AML, patient is older than 60 years old and not a candidate for standard chemotherapy
Patient is at least 4 weeks from prior treatment and has recovered from all prior treatment side effects
Patient has no known liver or kidney problems
Patient knows of no reason they can not receive transfusions of blood clotting cells (platelets)
Patient is able to swallow capsules
Patients both male and female are willing to practice birth control during the study
You may not be if
Patient has received prior treatment with valproic acid, decitabine or azacitidine
Being is less than 18 years of age or if patient has untreated AML is below 60 years of age
Patient is a women who is pregnant or breastfeeding. Patient has an active infection that requires antibiotics
Patient has uncontrolled illness including but not limited to the following: heart problems (congestive heart failure, unstable angina pectoris, cardiac arrhythmia), inflammation of the pancreas; a mental or social condition that may interfere with patient following study procedures
Patient has known human immunodeficiency virus (HIV) infection or HIV-related malignancy. Patient has a known history of hepatitis B or C infection
Patient currently has another active cancer other than certain types of skin cancer
Patient is heterosexual and able to have a child and is unwilling to practice birth control during the study